文献速递慢阻肺呼吸道感染

抗抑郁药与COPD患者肺炎及急性加重的关联:自身对照病例系列研究

Association between antidepressants with pneumonia and exacerbation in patients with COPD: a self-controlled case series (SCCS).
PubMed 文献 · Thorax · 2023-12-15

该自身对照病例系列研究基于英国健康改善网络数据,评估COPD患者使用抗抑郁药是否增加肺炎和COPD急性加重风险。处方后90天内肺炎风险增加79%(年龄校正IRR 1.79,95%CI 1.54–2.07),COPD急性加重风险增加16%(年龄校正IRR 1.16,95%CI 1.13–1.20),停药后风险消失或减弱。

要点

  • 抗抑郁药处方后90天内肺炎风险增加79%,停药后关联消失
  • 抗抑郁药处方后90天内COPD急性加重风险增加16%,停药后风险减弱
  • 建议密切监测抗抑郁药副作用并考虑非药物干预

核心结论

  • COPD患者使用抗抑郁药与肺炎及COPD急性加重风险增加相关,停药后风险减弱。

主要发现

  • 抗抑郁药处方后90天风险期内肺炎风险增加79%(年龄校正IRR 1.79,95%CI 1.54–2.07),停药后关联消失。
  • 抗抑郁药处方后90天内COPD急性加重风险增加16%(年龄校正IRR 1.16,95%CI 1.13–1.20),剩余期风险持续并略增至年龄校正IRR 1.38(95%CI 1.34–1.41),停药后减弱。

临床怎么用

  • 对COPD患者处方抗抑郁药时应密切监测肺炎和急性加重等副作用。
  • 可考虑非药物干预作为替代或辅助方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether antidepressant prescriptions are associated with an increased risk of pneumonia and chronic obstructive pulmonary disease (COPD) exacerbation. METHODS: A self-controlled case series was performed to investigate the rates of pneumonia and COPD exacerbation during periods of being exposed to antidepressants compared with non-exposed periods. Patients with COPD with pneumonia or COPD exacerbation and at least one prescription of antidepressant were ascertained from The Health Improvement Network in the UK. Incidence rate ratios (IRR) and 95% CI were calculated for both outcomes. RESULTS: Of 31 253 patients with COPD with at least one antidepressant prescription, 1969 patients had pneumonia and 18 483 had a COPD exacerbation. The 90-day risk period following antidepressant prescription was associated with a 79% increased risk of pneumonia (age-adjusted IRR 1.79, 95% CI 1.54 to 2.07). These associations then disappeared once antidepressants were discontinued. There was a 16% (age-adjusted IRR 1.16, 95% CI 1.13 to 1.20) increased risk of COPD exacerbation within the 90 days following antidepressant prescription. This risk persisted and slightly increased in the remainder period ((age-adjusted IRR 1.38, 95% CI 1.34 to 1.41), but diminished after patients discounted the treatment. CONCLUSION: Antidepressants were associated with an increased risk of both pneumonia and exacerbation in patients with COPD, with the risks diminished on stopping the treatment. These findings suggest a close monitoring of antidepressant prescription side effects and consideration of non-pharmacological interventions.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Siraj, Bolton, McKeever, et al. Association between antidepressants with pneumonia and exacerbation in patients with COPD: a self-controlled case series (SCCS). Thorax. 2023. PMID: 37336642. doi:10.1136/thorax-2022-219736

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。